Page last updated: 2024-09-03

sb 211475 and ascorbic acid

sb 211475 has been researched along with ascorbic acid in 1 studies

Compound Research Comparison

Studies
(sb 211475)
Trials
(sb 211475)
Recent Studies (post-2010)
(sb 211475)
Studies
(ascorbic acid)
Trials
(ascorbic acid)
Recent Studies (post-2010) (ascorbic acid)
60145,2612,49711,176

Protein Interaction Comparison

ProteinTaxonomysb 211475 (IC50)ascorbic acid (IC50)
Chain A, Hyaluronidase, phage associatedStreptococcus pyogenes1000
UreaseCanavalia ensiformis (jack bean)8.59
Solute carrier family 23 member 1Homo sapiens (human)156

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feuerstein, GZ; Gu, JL; Lysko, KA; Lysko, PG; Mckenna, PJ; Ruffolo, RR; Yue, TL1

Other Studies

1 other study(ies) available for sb 211475 and ascorbic acid

ArticleYear
SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.
    European journal of pharmacology, 1994, Jan-14, Volume: 251, Issue:2-3

    Topics: Adenosine Diphosphate; Animals; Antihypertensive Agents; Antioxidants; Ascorbic Acid; Brain; Carbazoles; Cattle; Cell Death; Cells, Cultured; Chromans; Endothelium, Vascular; Fumarates; Humans; Iron; Lipid Peroxidation; Lipoproteins, LDL; Macrophages; Male; Mice; Neurons; Neutrophils; Nicardipine; Oxidation-Reduction; Piperazines; Propanolamines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxides; Tetradecanoylphorbol Acetate; Xanthine; Xanthine Oxidase; Xanthines

1994